These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32861824)

  • 1. The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19.
    Sadasivam B; Atal S; Ray A; Sharma S
    Int J Infect Dis; 2020 Nov; 100():25-26. PubMed ID: 32861824
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.
    Shih RD; Johnson HM; Maki DG; Hennekens CH
    Am J Med; 2020 Sep; 133(9):1007-1008. PubMed ID: 32502485
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
    Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
    d'Arminio Monforte A; Tavelli A; Bai F; Marchetti G; Cozzi-Lepri A
    Int J Infect Dis; 2020 Oct; 99():75-76. PubMed ID: 32738491
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus.
    de Miranda Santos IKF; Costa CHN
    Front Immunol; 2020; 11():1739. PubMed ID: 32849619
    [No Abstract]   [Full Text] [Related]  

  • 6. Chloroquine and hydroxychloroquine in covid-19.
    Ferner RE; Aronson JK
    BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19.
    Monte Serrano J; Cruañes Monferrer J; García-García M; García-Gil MF
    Med Clin (Barc); 2020 Sep; 155(5):231. PubMed ID: 32522372
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients.
    Brito-Azevedo A
    Int J Infect Dis; 2020 Oct; 99():324. PubMed ID: 32768698
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.
    Cairoli E; Espinosa G
    Med Clin (Barc); 2020 Aug; 155(3):134-135. PubMed ID: 32425245
    [No Abstract]   [Full Text] [Related]  

  • 10. BET 2: Hydroxychloroquine in the treatment of COVID-19.
    Howard L; Baombe J; Reynard C
    Emerg Med J; 2020 Jul; 37(7):451-453. PubMed ID: 32616659
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.
    Delaleu J; Deniau B; Battistella M; de Masson A; Bensaid B; Jachiet M; Lazaridou I; Bagot M; Bouaziz JD;
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2777-2779.e1. PubMed ID: 32525093
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2.
    Neves FS
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):124-126. PubMed ID: 32801224
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.
    Grandolfo M; Romita P; Bonamonte D; Cazzato G; Hansel K; Stingeni L; Conforti C; Giuffrida R; Foti C
    Dermatol Ther; 2020 Jul; 33(4):e13499. PubMed ID: 32362051
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen.
    Pareek A; Bhandari S; Mehta RT
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):130-132. PubMed ID: 32811798
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel approach for low-dose pulmonary delivery of hydroxychloroquine in COVID-19.
    Fassihi SC; Nabar NR; Fassihi R
    Br J Pharmacol; 2020 Nov; 177(21):4997-4998. PubMed ID: 32562278
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
    Litaiem N; Hajlaoui K; Karray M; Slouma M; Zeglaoui F
    Dermatol Ther; 2020 Jul; 33(4):e13565. PubMed ID: 32401410
    [No Abstract]   [Full Text] [Related]  

  • 17. Myasthenic Syndrome Caused by Hydroxychloroquine Used for COVID-19 Prophylaxis.
    Koc G; Odabasi Z; Tan E
    J Clin Neuromuscul Dis; 2020 Sep; 22(1):60-62. PubMed ID: 32833728
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19: Important Therapy Considerations and Approaches in this Hour of Need.
    Lodise TP; Rybak MJ
    Pharmacotherapy; 2020 May; 40(5):379-381. PubMed ID: 32267556
    [No Abstract]   [Full Text] [Related]  

  • 19. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
    Palmeira VA; Costa LB; Perez LG; Ribeiro VT; Lanza K; Silva ACSE
    Clinics (Sao Paulo); 2020; 75():e1928. PubMed ID: 32401962
    [No Abstract]   [Full Text] [Related]  

  • 20. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
    Ingraham NE; Boulware D; Sparks MA; Schacker T; Benson B; Sparks JA; Murray T; Connett J; Chipman JG; Charles A; Tignanelli CJ
    Crit Care; 2020 Apr; 24(1):182. PubMed ID: 32345336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.